NORTH EAST FIRM SECURES PRESIDENT ZELENSKYY AT CHARLEMAGNE CEREMONY
Radiation detection equipment created by Kromek Group plc in Sedgefield has been used to secure President Zelenskyy at an awards ceremony in Germany on 14th May 2023.
Aachen police, supported by the EU Commission Protective Security Advisor team, in a proactive manner utilised the Kromek equipment to secure venues against radiological threats.
The Ukrainian President was visiting the city on Sunday 14th May to receive the Charlemagne Prize, an award presented for work done in the service of European unification. He then went on to visit world leaders in the UK, Italy and France to discuss further defence packages for his country.
Kromek’s portable radiological detector D3S was used at all security checkpoints along with other security equipment to ensure that the 750 special guests, including Germany’s Chancellor Schultz and President Zelenskyy, were secure during the special ceremony.
The mobile phone-sized detector is used to search and identify radioactive doses in the environment and give feedback to the user instantaneously.
Dr Arnab Basu, CEO of Kromek, said: “We’d like to extend our congratulations to President Zelenskyy on receipt of the Charlemagne Prize, and we are delighted to have played a part in ensuring he and the other VIPs remained safe during the ceremony.
“Like the rest of the world, we have followed the story of the war in Ukraine closely, and appreciate the concerns that the police in Aachen may have had in hosting this event, particularly given recent strikes on Kyiv.
“Kromek has provided essential, portable radiation detection equipment to a number of government agencies worldwide, and we will continue to develop our technology as potential threats evolve.”
CONTACT: JOSH MASON 01325 363436
About Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.
The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer’s, contamination in industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek’s compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of ‘dirty bombs’.
The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol ‘KMK’.
Further information is available at www.kromek.com.back to Kromek